SAN DIEGO, Oct. 22, 2026 /PRNewswire/ — Halozyme Therapeutics, Inc. (Nasdaq: HALO) (“Halozyme”) today announced it will release its third quarter 2026 financial and operating results on Thursday, November 5, 2026, following the close of trading. Halozyme will host a conference call on…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
